95 related articles for article (PubMed ID: 1526088)
1. Pharmacokinetics and pharmacodynamics of bambuterol, a long-acting bronchodilator pro-drug of terbutaline, in young and elderly patients with asthma.
Sitar DS; Warren CP; Aoki FY
Clin Pharmacol Ther; 1992 Sep; 52(3):297-306. PubMed ID: 1526088
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of bambuterol in subjects homozygous for the atypical gene for plasma cholinesterase.
Bang U; Nyberg L; Rosenborg J; Viby-Mogensen J
Br J Clin Pharmacol; 1998 May; 45(5):479-84. PubMed ID: 9643621
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of bambuterol in healthy subjects.
Nyberg L; Rosenborg J; Weibull E; Jönsson S; Kennedy BM; Nilsson M
Br J Clin Pharmacol; 1998 May; 45(5):471-8. PubMed ID: 9643620
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics of bambuterol.
Sitar DS
Clin Pharmacokinet; 1996 Oct; 31(4):246-56. PubMed ID: 8896942
[TBL] [Abstract][Full Text] [Related]
5. Comparative study using oral solutions of bambuterol once daily or terbutaline three times daily in 2-5-year-old children with asthma. Bambuterol Multicentre Study Group.
Kuusela AL; Marenk M; Sandahl G; Sanderud J; Nikolajev K; Persson B
Pediatr Pulmonol; 2000 Mar; 29(3):194-201. PubMed ID: 10686040
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of bambuterol during oral administration to asthmatic children.
Ahlström H; Alvero J; Alvero R; Espos R; Fajutrao L; Herrera J; Kjellman B; Kubista J; Leviste C; Meyer P; Oldaeus G; Siricururat A; Vichyanond P; Wettrell G; Wong E; Laxmyr L; Nyberg L; Olsson H; Weibull E; Rosenborg J
Br J Clin Pharmacol; 1999 Sep; 48(3):299-308. PubMed ID: 10510139
[TBL] [Abstract][Full Text] [Related]
7. Bambuterol in the treatment of asthma. A placebo-controlled comparison of once-daily morning vs evening administration.
D'Alonzo GE; Smolensky MH; Feldman S; Gnosspelius Y; Karlsson K
Chest; 1995 Feb; 107(2):406-12. PubMed ID: 7842769
[TBL] [Abstract][Full Text] [Related]
8. One-year safety study with bambuterol once daily and terbutaline three times daily in 2-12-year-old children with asthma. The Bambuterol Multicentre Study Group.
Zarkovic JP; Marenk M; Valovirta E; Kuusela AL; Sandahl G; Persson B; Olsson H
Pediatr Pulmonol; 2000 Jun; 29(6):424-9. PubMed ID: 10821722
[TBL] [Abstract][Full Text] [Related]
9. A placebo-controlled dose-finding study with bambuterol in elderly patients with asthma.
Sitar DS; Aoki FY; Warren CP; Knight A; Grossman RF; Alexander M; Soliman S
Chest; 1993 Mar; 103(3):771-6. PubMed ID: 8449067
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic equivalence between bambuterol, 10 mg once daily, and terbutaline controlled release, 5 mg twice daily, in mild to moderate asthma.
Fugleholm AM; Ibsen TB; Laxmyr L; Svendsen UG
Eur Respir J; 1993 Nov; 6(10):1474-8. PubMed ID: 8112441
[TBL] [Abstract][Full Text] [Related]
11. Bambuterol: dose response study of a new terbutaline prodrug in asthma.
Holstein-Rathlou NH; Laursen LC; Madsen F; Svendsen UG; Gnosspelius Y; Weeke B
Eur J Clin Pharmacol; 1986; 30(1):7-11. PubMed ID: 3519240
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of bambuterol during oral administration of plain tablets and solution to healthy adults.
Rosenborg J; Larsson P; Nyberg L
Br J Clin Pharmacol; 2000 Mar; 49(3):199-206. PubMed ID: 10718774
[TBL] [Abstract][Full Text] [Related]
13. Bambuterol: clinical effects of different doses of a long-acting bronchodilator prodrug.
Sandström T; Asander L; Clemmensen IH; Eklund G; Gnosspelius Y; Klarlund Pedersen B; Persson G; Ravn S; Rosenhall L; Weeke B
Respiration; 1988; 53(1):31-6. PubMed ID: 3387689
[TBL] [Abstract][Full Text] [Related]
14. Bambuterol, a carbamate ester prodrug of terbutaline, as inhibitor of cholinesterases in human blood.
Tunek A; Svensson LA
Drug Metab Dispos; 1988; 16(5):759-64. PubMed ID: 2906603
[TBL] [Abstract][Full Text] [Related]
15. Bambuterol, a bronchodilator prodrug with sustained action, enhances delivery of active drug to the lung.
Svensson LA
Agents Actions Suppl; 1988; 23():271-6. PubMed ID: 3262993
[TBL] [Abstract][Full Text] [Related]
16. Interactions of bambuterol with human serum cholinesterase of the genotypes EuEu (normal), EaEa (atypical) and EuEa.
Tunek A; Hjertberg E; Mogensen JV
Biochem Pharmacol; 1991 Feb; 41(3):345-8. PubMed ID: 1994894
[TBL] [Abstract][Full Text] [Related]
17. The effect of bambuterol (carbamylated terbutaline) on plasma cholinesterase activity and suxamethonium-induced neuromuscular blockade in genotypically normal patients.
Bang U; Viby-Mogensen J; Wirén JE; Skovgaard LT
Acta Anaesthesiol Scand; 1990 Oct; 34(7):596-9. PubMed ID: 2244449
[TBL] [Abstract][Full Text] [Related]
18. Bambuterol: clinical effects of three doses of bambuterol once daily in asthmatic patients.
Clemmensen IH; Pedersen BK; Ravn S; Laursen LC; Weeke B
Allergy; 1988 Nov; 43(8):573-6. PubMed ID: 3061311
[TBL] [Abstract][Full Text] [Related]
19. Bronchodilation and beta 2-selectivity of broxaterol in asthmatics: a crossover, single-blind, terbutaline- and placebo-controlled study.
Petraglia A; Gurrieri G; Scarpitta M; Pisati R; Ansalone D
Int J Clin Pharmacol Ther Toxicol; 1992 Oct; 30(10):365-70. PubMed ID: 1359998
[TBL] [Abstract][Full Text] [Related]
20. Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids.
Crompton GK; Ayres JG; Basran G; Schiraldi G; Brusasco V; Eivindson A; Jamieson AH; Olsson H
Am J Respir Crit Care Med; 1999 Mar; 159(3):824-8. PubMed ID: 10051257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
